Specializing in oncology, hematology, autoimmune disease, rheumatology and related clinical fields, LEOconsulting provides competent advice on clinical development of targeted therapies, all with an impressive track record. Areas of expertise include preclinical development to phase III clinical research — with support for the development of antibodies, antibody derivatives, small molecules, antisense therapies and vaccines. Support for translational research, tailored biomarker identification and development, competent agency interactions and outside representation are also covered. LEOconsulting has the proven skill-set and experience necessary to support the successful clinical development of your compounds.

Click SERVICES to learn more.